Results 41 to 50 of about 147,745 (262)

THE EXPRESSION OF TGF-1 AFTER LOW LEVEL LASER THERAPY IN INFLAMMATION ANIMAL MODEL

open access: yesFolia Medica Indonesiana, 2017
Pain is the most common complaints in everyday practice. Pain is a clinical manifestation caused by stimuli due to potential tissue damage. Low level laser therapy (LLLT) has been used in reducing pain.
Imam Subadi   +2 more
doaj   +1 more source

EDNRB‐dependent endothelin signaling reduces proliferation and promotes proneural‐to‐mesenchymal transition in gliomas

open access: yesMolecular Oncology, EarlyView.
Glioma cells mainly express the endothelin receptor EDNRB, while EDNRA is restricted to a perivascular tumor subpopulation. Endothelin signaling reduces glioma cell proliferation while promoting migration and a proneural‐to‐mesenchymal transition associated with poor prognosis. This pathway activates Ca2+, K+, ERK, and STAT3 signalings and is regulated
Donovan Pineau   +36 more
wiley   +1 more source

Low-level laser therapy combined with postural correction exercises on postpartum sacroiliac joint pain: a randomised controlled trial

open access: yesPhysiotherapy Quarterly
Introduction Sacroiliac joint (SIJ) pain is a common problem that affects women during and after pregnancy and restricts their daily activities. It can be treated with various physiotherapy interventions, including exercises, patient education, and pain ...
Manal A El-Shafei   +4 more
doaj   +1 more source

LOW LEVEL LASER THERAPY ON EXPERIMENTAL MYOPATHY

open access: yesLASER THERAPY, 2011
The aim of the present work was to study the effect of Helium-Neon (HeNe) and Gallium Arsenide (GaAs) laser upon nitric oxide (NO) plasma levels, an inflammatory biomarker associated with oxidative stress, in rats with experimental myopathy. These were evaluated through histological assessment.The groups studied were: (A) control (intact rats that ...
Dávila, Soledad   +5 more
openaire   +3 more sources

Low-level laser therapy for migraine

open access: yesHeadache Medicine, 2021
Correspondence
Marcio Rafael de Araujo Siega   +1 more
openaire   +2 more sources

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Low-level Laser Therapy in Knee Osteoarthritis: A Prospective Analytical Study

open access: yesJournal of Clinical Orthopaedics
Background/Aims: Osteoarthritis (OA) is the second common rheumatologic disorder and the most prevalent joint disease in India, affecting 20–40% of the population.
V Sriram, Nrupatunga K K, L Sachin Patel
doaj   +1 more source

In dogs does low level laser therapy reduce healing time?

open access: yesVeterinary Evidence, 2020
PICO question In dogs with a surgical or open wound does low level laser therapy increase the speed of wound contracture and reduce the healing time?   Clinical bottom line Category of research question Treatment The number and type of
Emma Jane Suiter
doaj   +1 more source

Factors affecting Low Level Laser Therapy

open access: yesAustralian Journal of Physiotherapy, 1993
Low Level Laser Therapy has been reported as causing many therapeutic reactions within living tissue, yet research studies have not been able to support conclusively the results which appear to occur clinically. If the physiotherapist accepts that light quality may have been a variable overlooked in previous studies, it is necessary to consider whether
Laakso, Liisa   +2 more
openaire   +4 more sources

Low-level laser therapy as a treatment for chronic pain [PDF]

open access: yesFrontiers in Physiology, 2014
Chronic pain is defined as pain that persists for greater than 12 weeks (Task-Force, 1994) and currently affects roughly 30% of the population in the United States (Johannes et al., 2010). The most common method for managing chronic pain has traditionally been pharmacological (Nalamachu, 2013).
Kingsley, J. Derek   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy